• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床实践中骨转换生化标志物的实验室可重复性。

Laboratory reproducibility of biochemical markers of bone turnover in clinical practice.

机构信息

Department of Medicine, University of California, San Francisco, CA, USA.

出版信息

Osteoporos Int. 2010 Mar;21(3):439-45. doi: 10.1007/s00198-009-0974-2. Epub 2009 Jun 9.

DOI:10.1007/s00198-009-0974-2
PMID:19506793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2817087/
Abstract

SUMMARY

To determine the laboratory reproducibility of urine N-telopeptide and serum bone-specific alkaline phosphatase measurements, we sent identical specimens to six US commercial labs over an 8-month period. Longitudinal and within-run laboratory reproducibility varied substantially. Efforts to improve the reproducibility of these tests are needed.

INTRODUCTION

We assessed the laboratory reproducibility of urine N-telopeptide (NTX) and serum bone-specific alkaline phosphatase (BAP).

METHODS

Serum and urine were collected from five postmenopausal women, pooled, divided into identical aliquots, and frozen. To evaluate longitudinal reproducibility, identical specimens were sent to six US commercial labs on five dates over an 8-month period. To evaluate within-run reproducibility, on the fifth date, each lab was sent five identical specimens. Labs were unaware of the investigation.

RESULTS

Longitudinal coefficients of variation (CVs) ranged from 5.4% to 37.6% for NTX and from 3.1% to 23.6% for BAP. Within-run CVs ranged from 1.5% to 17.2% for NTX. Compared to the Osteomark NTX assay, the Vitros ECi NTX assay had significantly higher longitudinal reproducibility (mean CV 7.2% vs. 30.3%, p < 0.0005) and within-run reproducibility (mean CV 3.5% vs. 12.7%, p < 0.0005).

CONCLUSIONS

Reproducibility of urine NTX and serum BAP varies substantially across US labs.

摘要

摘要

为了确定尿 N-端肽和血清骨特异性碱性磷酸酶测量的实验室重现性,我们在 8 个月的时间内将相同的标本送到 6 个美国商业实验室。纵向和实验室内部重复性变化很大。需要努力提高这些测试的重现性。

引言

我们评估了尿 N-端肽(NTX)和血清骨特异性碱性磷酸酶(BAP)的实验室重现性。

方法

从 5 名绝经后妇女收集血清和尿液,混合,分成相同的等分试样,并冷冻。为了评估纵向重复性,在 8 个月的时间内,将相同的标本分 5 批送到 6 个美国商业实验室。为了评估实验室内部重复性,在第 5 天,每个实验室都收到了 5 个相同的标本。实验室不知道这项调查。

结果

纵向变异系数(CV)范围为 5.4%至 37.6%的 NTX 和 3.1%至 23.6%的 BAP。NTX 的实验室内部 CV 范围为 1.5%至 17.2%。与 Osteomark NTX 测定相比,Vitros ECi NTX 测定具有更高的纵向重复性(平均 CV 7.2%对 30.3%,p<0.0005)和实验室内部重复性(平均 CV 3.5%对 12.7%,p<0.0005)。

结论

美国各实验室之间尿 NTX 和血清 BAP 的重现性差异很大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e977/2817087/f7474cd04ffd/198_2009_974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e977/2817087/50424d4eb12c/198_2009_974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e977/2817087/f7474cd04ffd/198_2009_974_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e977/2817087/50424d4eb12c/198_2009_974_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e977/2817087/f7474cd04ffd/198_2009_974_Fig2_HTML.jpg

相似文献

1
Laboratory reproducibility of biochemical markers of bone turnover in clinical practice.临床实践中骨转换生化标志物的实验室可重复性。
Osteoporos Int. 2010 Mar;21(3):439-45. doi: 10.1007/s00198-009-0974-2. Epub 2009 Jun 9.
2
Commercial Laboratory Reproducibility of Serum CTX in Clinical Practice.血清CTX在临床实践中的商业实验室再现性。
JBMR Plus. 2019 Aug 28;3(10):e10225. doi: 10.1002/jbm4.10225. eCollection 2019 Oct.
3
Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.孕期卧床休息对孕妇及产后女性骨转换标志物的影响。
Bone. 2007 Apr;40(4):1088-94. doi: 10.1016/j.bone.2006.11.018. Epub 2007 Jan 16.
4
A new approach for evaluating bone turnover in chronic kidney disease.评估慢性肾脏病中骨转换的新方法。
Eur J Intern Med. 2010 Jun;21(3):230-2. doi: 10.1016/j.ejim.2010.01.013. Epub 2010 Feb 18.
5
Association between bone turnover, micronutrient intake, and blood lead levels in pre- and postmenopausal women, NHANES 1999-2002.绝经前和绝经后妇女的骨转换、微量营养素摄入与血铅水平之间的关系,NHANES 1999-2002。
Environ Health Perspect. 2010 Nov;118(11):1590-6. doi: 10.1289/ehp.1002158.
6
The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.骨转换生化标志物对日本绝经后女性骨密度的预测价值。
J Bone Miner Res. 2000 Aug;15(8):1537-44. doi: 10.1359/jbmr.2000.15.8.1537.
7
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.骨转换生化标志物在评估佩吉特病治疗反应中的应用价值。
Bone. 2001 Nov;29(5):447-52. doi: 10.1016/s8756-3282(01)00592-0.
8
The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.60岁以下绝经后女性循环胰岛素样生长因子成分、骨转换生化标志物与骨密度之间的关系。
Clin Endocrinol (Oxf). 1999 Sep;51(3):301-7. doi: 10.1046/j.1365-2265.1999.00769.x.
9
Urinary excretion of type I collagen cross-linked N-telopeptide and serum bone-specific alkaline phosphatase analysis to determine the correlation of age and back-pain related changes in elderly women.通过分析I型胶原交联N-端肽的尿排泄情况和血清骨特异性碱性磷酸酶,以确定老年女性年龄与背痛相关变化之间的相关性。
J Bone Miner Metab. 2005;23(6):495-500. doi: 10.1007/s00774-005-0634-3.
10
The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.甲氨蝶呤对类风湿关节炎患者骨代谢标志物的影响。
Mod Rheumatol. 2006;16(6):350-4. doi: 10.1007/s10165-006-0517-z. Epub 2006 Dec 20.

引用本文的文献

1
Clinical use of bone markers: a challenge to variability.骨标志物的临床应用:变异性带来的挑战。
Adv Lab Med. 2023 Aug 28;5(1):7-14. doi: 10.1515/almed-2023-0092. eCollection 2024 Mar.
2
[Not Available].[无可用内容]
Adv Lab Med. 2023 Jul 24;5(1):15-23. doi: 10.1515/almed-2023-0041. eCollection 2024 Mar.
3
Energy Metabolism and Ketogenic Diets: What about the Skeletal Health? A Narrative Review and a Prospective Vision for Planning Clinical Trials on this Issue.能量代谢与生酮饮食:骨骼健康如何?关于这个问题的叙述性综述和临床试验规划的前瞻性展望。

本文引用的文献

1
Correlation among 25-hydroxy-vitamin D assays.25-羟基维生素D检测之间的相关性。
J Clin Endocrinol Metab. 2008 May;93(5):1804-8. doi: 10.1210/jc.2007-2340. Epub 2008 Mar 4.
2
Comparison of immunoradiometric assays for determination of thyroglobulin: a validation study.用于测定甲状腺球蛋白的免疫放射分析方法比较:一项验证研究。
J Clin Lab Anal. 2007;21(3):147-53. doi: 10.1002/jcla.20156.
3
Comparison of methods to measure low serum estradiol levels in postmenopausal women.绝经后女性低血清雌二醇水平测量方法的比较。
Int J Mol Sci. 2021 Jan 4;22(1):435. doi: 10.3390/ijms22010435.
4
Commercial Laboratory Reproducibility of Serum CTX in Clinical Practice.血清CTX在临床实践中的商业实验室再现性。
JBMR Plus. 2019 Aug 28;3(10):e10225. doi: 10.1002/jbm4.10225. eCollection 2019 Oct.
5
Medical Diagnostic Tests: A Review of Test Anatomy, Phases, and Statistical Treatment of Data.医学诊断测试:测试解剖学、阶段和数据统计处理的回顾。
Comput Math Methods Med. 2019 May 28;2019:1891569. doi: 10.1155/2019/1891569. eCollection 2019.
6
Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.丹麦人群中两种 BTM(CTX 和 P1NP)自动化检测方法与参考区间的比较。
Osteoporos Int. 2017 Jul;28(7):2103-2113. doi: 10.1007/s00198-017-4026-z. Epub 2017 Apr 28.
7
Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia.骨质疏松症绝经后女性中骨转换标志物对雷洛昔芬治疗的反应。
Osteoporos Int. 2016 Aug;27(8):2585-92. doi: 10.1007/s00198-016-3573-z. Epub 2016 Mar 30.
8
Chronic kidney disease and the skeleton.慢性肾脏病与骨骼
Bone Res. 2014 Dec 23;2:14044. doi: 10.1038/boneres.2014.44. eCollection 2014.
9
Bone remodeling markers and bone metastases: From cancer research to clinical implications.骨重塑标志物与骨转移:从癌症研究到临床意义
Bonekey Rep. 2015 Apr 22;4:668. doi: 10.1038/bonekey.2015.35. eCollection 2015.
10
The clinical utility of bone marker measurements in osteoporosis.骨标志物测量在骨质疏松症中的临床应用。
J Transl Med. 2013 Aug 29;11:201. doi: 10.1186/1479-5876-11-201.
J Clin Endocrinol Metab. 2006 Oct;91(10):3791-7. doi: 10.1210/jc.2005-2378. Epub 2006 Aug 1.
4
Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL.用于测量循环氧化低密度脂蛋白的免疫分析方法的分析性能和诊断准确性。
Clin Chem. 2006 Apr;52(4):760-4. doi: 10.1373/clinchem.2005.064337. Epub 2006 Feb 23.
5
Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization.检测结果的差异干扰了维生素D缺乏症的诊断:呼吁标准化。
J Clin Endocrinol Metab. 2004 Jul;89(7):3152-7. doi: 10.1210/jc.2003-031979.
6
Editorial: The determination of circulating 25-hydroxyvitamin D: no easy task.社论:循环25-羟维生素D的测定:并非易事。
J Clin Endocrinol Metab. 2004 Jul;89(7):3149-51. doi: 10.1210/jc.2004-0682.
7
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial.阿仑膦酸钠治疗女性的骨转换变化及髋部、非脊柱和椎体骨折:骨折干预试验
J Bone Miner Res. 2004 Aug;19(8):1250-8. doi: 10.1359/JBMR.040512. Epub 2004 May 24.
8
Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk.雷洛昔芬治疗对骨代谢标志物PINP的降低作用及其与椎体骨折风险的关系。
Bone. 2004 Feb;34(2):344-51. doi: 10.1016/j.bone.2003.10.004.
9
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.骨吸收早期变化与利塞膦酸盐降低骨折风险之间的关系。
J Bone Miner Res. 2003 Jun;18(6):1051-6. doi: 10.1359/jbmr.2003.18.6.1051.
10
Comparison study of urinary pyridinoline and deoxypyridinoline measurements in 13 US laboratories.
Clin Chem. 2001 Nov;47(11):2029-31.